{"title":"氯巴扎姆口腔溶解条的优化设计和体内外评估","authors":"Rajni Bala, Sushil Khanna, Pravin Pawar","doi":"10.1155/2014/392783","DOIUrl":null,"url":null,"abstract":"<p><p>Clobazam orally dissolving strips were prepared by solvent casting method. A full 3(2) factorial design was applied for optimization using different concentration of film forming polymer and disintegrating agent as independent variable and disintegration time, % cumulative drug release, and tensile strength as dependent variable. In addition the prepared films were also evaluated for surface pH, folding endurance, and content uniformity. The optimized film formulation showing the maximum in vitro drug release, satisfactory in vitro disintegration time, and tensile strength was selected for bioavailability study and compared with a reference marketed product (frisium5 tablets) in rabbits. Formulation (F6) was selected by the Design-expert software which exhibited DT (24 sec), TS (2.85 N/cm(2)), and in vitro drug release (96.6%). Statistical evaluation revealed no significant difference between the bioavailability parameters of the test film (F6) and the reference product. The mean ratio values (test/reference) of C max (95.87%), t max (71.42%), AUC0-t (98.125%), and AUC0-∞ (99.213%) indicated that the two formulae exhibited comparable plasma level-time profiles. </p>","PeriodicalId":15575,"journal":{"name":"Journal of drug delivery","volume":"2014 ","pages":"392783"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195261/pdf/","citationCount":"0","resultStr":"{\"title\":\"Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazam.\",\"authors\":\"Rajni Bala, Sushil Khanna, Pravin Pawar\",\"doi\":\"10.1155/2014/392783\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Clobazam orally dissolving strips were prepared by solvent casting method. A full 3(2) factorial design was applied for optimization using different concentration of film forming polymer and disintegrating agent as independent variable and disintegration time, % cumulative drug release, and tensile strength as dependent variable. In addition the prepared films were also evaluated for surface pH, folding endurance, and content uniformity. The optimized film formulation showing the maximum in vitro drug release, satisfactory in vitro disintegration time, and tensile strength was selected for bioavailability study and compared with a reference marketed product (frisium5 tablets) in rabbits. Formulation (F6) was selected by the Design-expert software which exhibited DT (24 sec), TS (2.85 N/cm(2)), and in vitro drug release (96.6%). Statistical evaluation revealed no significant difference between the bioavailability parameters of the test film (F6) and the reference product. The mean ratio values (test/reference) of C max (95.87%), t max (71.42%), AUC0-t (98.125%), and AUC0-∞ (99.213%) indicated that the two formulae exhibited comparable plasma level-time profiles. </p>\",\"PeriodicalId\":15575,\"journal\":{\"name\":\"Journal of drug delivery\",\"volume\":\"2014 \",\"pages\":\"392783\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195261/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of drug delivery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2014/392783\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/9/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/392783","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/9/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
氯巴扎姆口腔溶解条采用溶剂浇铸法制备。以不同浓度的成膜聚合物和崩解剂为自变量,崩解时间、累积药物释放率和拉伸强度为因变量,采用 3(2) 全因子设计进行优化。此外,还对制备的薄膜进行了表面 pH 值、耐折度和含量均匀性评估。优化后的薄膜配方显示出最大的体外药物释放量、令人满意的体外崩解时间和拉伸强度,被选中进行生物利用度研究,并与市场上的参考产品(frisium5 片剂)在兔子身上进行比较。通过 Design-expert 软件筛选出的制剂(F6)显示出 DT(24 秒)、TS(2.85 N/cm(2))和体外药物释放率(96.6%)。统计评估显示,试验薄膜(F6)和参照产品的生物利用度参数没有明显差异。C max (95.87%)、t max (71.42%)、AUC0-t (98.125%) 和 AUC0-∞ (99.213%) 的平均比值(试验/参照)表明,两种配方的血浆水平-时间曲线具有可比性。
Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazam.
Clobazam orally dissolving strips were prepared by solvent casting method. A full 3(2) factorial design was applied for optimization using different concentration of film forming polymer and disintegrating agent as independent variable and disintegration time, % cumulative drug release, and tensile strength as dependent variable. In addition the prepared films were also evaluated for surface pH, folding endurance, and content uniformity. The optimized film formulation showing the maximum in vitro drug release, satisfactory in vitro disintegration time, and tensile strength was selected for bioavailability study and compared with a reference marketed product (frisium5 tablets) in rabbits. Formulation (F6) was selected by the Design-expert software which exhibited DT (24 sec), TS (2.85 N/cm(2)), and in vitro drug release (96.6%). Statistical evaluation revealed no significant difference between the bioavailability parameters of the test film (F6) and the reference product. The mean ratio values (test/reference) of C max (95.87%), t max (71.42%), AUC0-t (98.125%), and AUC0-∞ (99.213%) indicated that the two formulae exhibited comparable plasma level-time profiles.